Carregant...
Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
BACKGROUND: Migraine prevention with erenumab and migraine induction by calcitonin gene-related peptide (CGRP) both carry notable individual variance. We wanted to explore a possible association between individual efficacy of anti-CGRP treatment and susceptibility to migraine induction by CGRP. METH...
Guardat en:
| Publicat a: | J Headache Pain |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Milan
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6755614/ https://ncbi.nlm.nih.gov/pubmed/30409109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0927-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|